Aminex PLC
1 May 2002
AMINEX PLC
("Aminex" or "the Company")
Following the Irish High Court's approval of Aminex's share capital reduction
announced on 29 April 2002, Aminex now confirms that the amount per Ordinary
share that each Aminex shareholder on the register at close of business on 29
April 2002 will receive is as follows:
In euros: EURO 10.75 cents
(to Aminex shareholders with Irish registered
addresses)
In sterling: Sterling 6.65 pence*
(to Aminex shareholders with United Kingdom or Channel
Island addresses)
In US dollars: US 9.7 cents
(to all other Aminex shareholders)
* The reason for the difference between this amount and the amount of 6.9p per
share published in the Company's circular of 13 February 2002 is the subsequent
strengthening of sterling against the dollar.
The following exchange rates have been applied:
US$1 : EURO 0.9029
£1 : US$1.4596
1 May 2002
Enquiries:
Aminex PLC Tel: 020 7240 1600
Brian Hall, Chief Executive
Davy Corporate Finance Tel: +353 1 679 6363
Hugh McCutcheon
Old Mutual Securities Tel: 020 7002 4618
Frank Moxon
College Hill Tel: 020 7457 2020
Archie Berens
Dennehy Associates Tel: +353 1 676 4733
Michael Dennehy
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.